Medicines Patent Pool signs deals for generic Roche flu drug in 129 nations
A U.N.-backed agency brokered sub-licensing agreements with eleven manufacturers to produce generic versions of a Roche influenza treatment for distribution across 129 countries.
Agreements cover low-income regions
The Medicines Patent Pool facilitated contracts allowing companies to develop and supply Xofluza in nearly all low- and middle-income nations. These manufacturers receive technical data and reference products required for bioequivalence studies. This support helps them secure regulatory approval in the targeted countries.
Pandemic preparedness goals drive deal
Officials view this arrangement as a step toward better pandemic preparedness by ensuring medication availability during outbreaks. The initiative represents an ongoing effort to balance financial priorities with patient access needs. Such collaborations aim to make essential medicines affordable for the largest number of patients possible.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.